Institute Of Hematology & Blood Diseases Hospital, China

This study tested whether a low-dose drug called decitabine could help patients with severe aplastic anemia who didn't improve with standard treatments. The trial aimed to see if the drug could boost blood cell counts and reduce the need for blood transfusions. Only three patient…

This early-stage study tested a drug called Linperlisib for adults with autoimmune hemolytic anemia (AIHA) whose disease returned or didn't improve after at least two standard treatments. The goal was to see if the drug could safely help control the disease by improving blood cou…

This early-stage study tested a new type of treatment called LCAR-AMDR, a CAR-T cell therapy, for adults and teens with acute myeloid leukemia (AML) that has come back or hasn't responded to standard treatments. The main goals were to find a safe dose and see if the therapy could…

This study tested whether combining the drugs venetoclax with azacytidine or DA could prevent relapse in acute myeloid leukemia (AML) patients who still had small amounts of cancer cells after initial treatment. The goal was to see if this 'preemptive' treatment could keep patien…

This study analyzed genetic patterns in 500 adult acute myeloid leukemia (AML) patients in China. Researchers examined how specific IDH1/2 mutations affect patient survival and relapse rates. The goal was to better understand which genetic changes predict better or worse outcomes…